PYCARD and cancer: While ASCf/fK14-Cre+ mice developed more tumors than controls, ASCf/f-LysM-Cre+ mice were protected against cancer, suggesting that in contrast to its pro-inflammatory role in myeloid cells, ASC acts as a tumor-suppressor in skin epithelial cells [10].